Navigation Links
Studies Show Genetic Activity of Antioxidants
Date:7/21/2009

Clues found on how they help arteries stay clear and healthy

TUESDAY, July 21 (HealthDay News) -- Using the latest genetic technology, researchers have begun to discover the exact molecular reasons why foods such as turmeric -- a popular curry spice -- and ordinary orange juice are good for the health of hearts and arteries.

Two French research teams are reporting studies describing the range of genes that are affected by curcumin, the active ingredient in turmeric, and hesperidin, an antioxidant that is a prominent component of orange juice. Their reports were delivered at the American Heart Association's Basic Cardiovascular Sciences Conference 2009, held in Lake Las Vegas.

"We used a microarray approach," said Dragan Milenkovic, a research scientist at the Centre de Clermont-Ferrand/Thiex in Saint Genes Champanelle, who described the turmeric study. "We have slides with samples of all the genes and we compared the expression of each gene to see which of them had their activity modified by exposure to curcumin."

The molecular study was done with mouse genes, and was preceded by a trial in living mice. The researchers used curcumin, which is a polyphenol, a form of antioxidant. Like other antioxidants, curcumin is known to help prevent against arterial buildup of plaque, the fatty deposits that eventually can block blood vessels.

The molecular study was preceded by a trial in which mice given a daily curcumin supplement for 16 weeks were found to have a 26 percent lower level of fat deposits in the aorta, the main artery of the heart.

The researchers then isolated genetic material from the mice and exposed it to curcumin. They found altered expression of 2,252 genes, whose activity included cellular signaling and adhesion, inflammation and fat metabolism.

The orange juice study was done by a different team of researchers at the same institute, in human volunteers. Twenty-four men who were healthy overall but who had cardiovascular risk factors such as obesity took part. In three one-month periods, the men drank one of three drinks a day: 500 milliliters of orange juice (containing 292 milligrams of hesperidin), 500 milliliters of an energy drink, or 500 milliliters of the same drink enriched with 292 milligrams of hesperidin.

The study found a trend toward improved blood pressure and better function of the endothelium, the delicate inner lining of blood vessels, in the men who consumed hesperidin, either in orange juice or as a supplement. Genetic studies found that hesperidin affected activity of 1,820 genes from white blood cells.

Neither experiment is a reason to take a supplement of either curcumin or hesperidin, Milenkovic said. "Some of these at high doses can be bad," he said of supplements in general. "They can be beneficial for the health if used in nutritional doses."

Nutritional supplements are always attractive to a lot of people, said Dr. Thomas L. Force, professor of medicine at Thomas Jefferson University, and a spokesman for the American Heart Association.

"They are of significant interest to the lay public, given the fascination with this approach to the prevention of disease," said Force, who is also clinical director of the university's Center for Translational Medicine. "People have an aversion to taking medicines."

But neither of the two studies adds definitive information about the preventive value of the nutrients, Force said. "They are add-ons to studies that have shown the possible value of antioxidants," he said. "Most of the literature is not at a very mechanistic level or picks out one specific protein that is regulated. These studies do provide a more global approach to how these compounds may function to do what they are purported to do."

And the studies are too preliminary to form the basis of dietary recommendations, Force said. "We can't make dietary recommendations until more studies are done," he said. "These may open the way to doing more studies."

More information

Learn about turmeric from the U.S. National Center for Complementary and Alternative Medicine.



SOURCES: Dragan Milenkovic, Ph.D., research scientist, Centre de Clermont-Ferrand/Thiex, Saint Genes Champanelle, France; Thomas L. Force, M.D., professor, medicine, and clinical director, Center for Translational Medicine, Thomas Jefferson University, Philadelphia; July 20, 2009, American Heart Association Basic Cardiovascular Sciences Conference, Lake Las Vegas


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Gene Studies of Male-Female Differences Often Flawed
2. Two studies published in the Lancet
3. Study of Studies Finds No Risk to Children From Phthalates in Toys
4. Just Completed Studies Reveal Impact of New Medicare Reimbursement Regulations
5. Studies Prove Exercise Can Heal the Body Mind and Soul
6. Studies Shed New Light on Breast Cancer, Treatment
7. Multi-Year Compendium of Pharmaceutical Case Studies Available from Best Practices, LLC
8. Genomic Health Announces Multiple Studies on Oncotype DX(TM) Presented at 2007 American Society of Clinical Oncology (ASCO) Breast Cancer Symposium
9. Best Practice Database: Complimentary Excerpt of Three Sales Force Excellence Studies
10. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
11. NIH awards Einstein multimillion dollar grant to extend studies of exceptional longevity
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Studies Show Genetic Activity of Antioxidants
(Date:2/10/2016)... (PRWEB) , ... February 10, 2016 , ... ... company is unveiling its revolutionary new 2.0 version at the International Roofing Expo ... “put the power of the world's most advanced weather technology in the hands ...
(Date:2/10/2016)... Garland, TX (PRWEB) , ... February 10, 2016 ... ... the commencement of a master charity program created to assist the local community. ... closely with community leaders and nonprofit organizations in the area. Their goal is ...
(Date:2/10/2016)... ... , ... Ongoing news of the ravages of traumatic brain injury (TBI) among ... that takes a closer look at cases of TBI being managed by their members. ... among the aging population, and identifies the challenges associated with their care. , During ...
(Date:2/10/2016)... ... 2016 , ... Armune BioScience signed a definitive agreement with ... centers across the country. Launched in April of 2015, Apifiny is the only cancer ... Apifiny order volume exceeded 3,000 tests in 2015. Primary care physicians and urologists have ...
(Date:2/10/2016)... ... February 10, 2016 , ... The ... been awarded the prestigious Distinguished Emerald Club of the World award, as determined ... magazine, one of the most respected trade publications serving private clubs. , “We’d ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... Jersey and OR AKIVA, Israel ... Regentis Biomaterials Ltd., a leader in the ... Series D investment round on February 5, 2016. The ... Group ("Haisco"), a leading Chinese pharmaceutical manufacturer, and ... SCP Vitalife Partners, Generali Financial Holdings and both the ...
(Date:2/10/2016)... Feb. 10, 2016  Silicon Biosystems Menarini Inc., ... that help uncover the biological complexities of disease ... a developer of innovative technologies for genomics research, ... aimed at enabling translational researchers to obtain high-quality ... hundred tumor and normal cells in an optimized ...
(Date:2/10/2016)... 2016 On Tuesday, February 9th, the ... with its Arthritis Advisory Committee to discuss ... & Johnson,s Remicade and most likely the ... U.S. The Biologics Prescribers Collaborative (BPC) along ... for Patient Access, American Association of Clinical ...
Breaking Medicine Technology: